1016976-13-8 Usage
Uses
Used in Pharmaceutical Industry:
3-Benzyloxy-4-iodo-5-nitro-benzaldehyde is used as an intermediate in the synthesis of various pharmaceutical compounds. Its unique structure and reactivity make it suitable for the development of new drugs with potential therapeutic applications.
Used in Chemical Industry:
3-Benzyloxy-4-iodo-5-nitro-benzaldehyde is used as a versatile building block in the synthesis of various chemical compounds. Its ability to participate in a range of chemical reactions allows for the creation of diverse products with different properties and applications.
Used in Agrochemical Industry:
3-Benzyloxy-4-iodo-5-nitro-benzaldehyde is used as an intermediate in the production of agrochemical compounds, such as pesticides and herbicides. Its unique chemical properties contribute to the development of effective and targeted agrochemical products.
Check Digit Verification of cas no
The CAS Registry Mumber 1016976-13-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,6,9,7 and 6 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1016976-13:
(9*1)+(8*0)+(7*1)+(6*6)+(5*9)+(4*7)+(3*6)+(2*1)+(1*3)=148
148 % 10 = 8
So 1016976-13-8 is a valid CAS Registry Number.
1016976-13-8Relevant articles and documents
Development of a flexible strategy towards FR900482 and the mitomycins
Trost, Barry M.,O'Boyle, Brendan M.,Torres, Wildeliz,Ameriks, Michael K.
supporting information; experimental part, p. 7890 - 7903 (2011/08/06)
FR900482 and the mitomycins are two intriguing classes of alkaloid natural products that have analogous biological mechanisms and obvious structural similarity. Both classes possess potent anticancer activity, a feature that has led to their investigation
Synthesis of 7-Epi (+)-FR900482: An epimer of comparable anti-cancer activity
Trost, Barry M.,O'Boyle, Brendan M.
supporting information; experimental part, p. 1369 - 1372 (2009/04/10)
(Chemical Equation Presented) FR900482 is a potent anti-tumor therapeutic that has been investigated as a replacement candidate for the clinically useful Mitomycin C. Herein, we report synthesis and biological testing of 7-Epi (+)-FR900482, which demonstrates equal potency relative to the natural product against several cancer cell lines. Highlights of this work include utilization of our palladium-catalyzed DYKAT methodology and development of a Polonovski oxidative ring expansion strategy to yield this equipotent epimer in 23 linear steps.
